Effect of phototherapy on the ductus arteriosus diameter in extremely premature infants: A randomised controlled

Davut Bozkaya1, Evrim Alyamaç Dizdar1, Ömer Ertekin1

  • 1Division of Neonatology, Ankara Bilkent City Hospital, University of Health Sciences, Ankara, Turkey.

PubMed

Insights

Shielding infants during phototherapy (PT) significantly reduced the severity of patent ductus arteriosus (PDA). This protective measure lowered the incidence of hemodynamically significant PDA in premature infants.

Area of Science:

  • Neonatology
  • Pediatric Cardiology
  • Neonatal Intensive Care

Background:

  • Patent ductus arteriosus (PDA) is a frequent complication in preterm infants (<1000g), linked to increased mortality and morbidity.
  • Phototherapy (PT) is a standard treatment for jaundice in premature infants.
  • Previous studies on the relationship between PT and PDA have yielded inconclusive results.

Purpose of the Study:

  • To investigate the impact of phototherapy on PDA parameters in premature infants.
  • To assess the effect of shielding during phototherapy on PDA development.

Main Methods:

  • Prospective, randomized, double-blind study involving 83 infants (<1000g, <30 weeks gestation).
  • Infants were divided into shielded and non-shielded groups during phototherapy.
  • Doppler echocardiography was used to evaluate PDA parameters before and after phototherapy.

Main Results:

  • The shielded group showed a significant decrease in hemodynamically significant PDA (hs-PDA) and left atrial/aortic root ratio.
  • The need for PDA treatment was significantly lower in the shielded group.
  • Phototherapy duration was comparable between groups.

Conclusions:

  • Shielding during phototherapy effectively reduces the incidence and severity of hs-PDA in extremely premature infants.
  • This intervention may mitigate a significant complication associated with neonatal care.

Related Concept Videos